Capitol Hill NIH cuts threaten U.S. edge in biomedical research: “We are giving China the opportunity of a lifetime”Cancer research also took center stage at Senate appropriations hearing May 02, 2025Vol.51 No.17By Claire Marie Porter
Bertagnolli: NIH funding cuts are “unprecedented and harmful”AACR panel challenges scientists to find stability in a period of “ventricular tachycardia” May 02, 2025Vol.51 No.17By Claire Marie Porter
Sponsored Advancing quality of life in oncology: A journey of compassion and innovation May 02, 2025Vol.51 No.17By Betty Ferrell
Conversation with The Cancer Letter Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health April 25, 2025Vol.51 No.16By Paul Goldberg
Guest Editorial In her own words: Rathmell reflects on her priorities and values—and encourages everyone to do the same April 25, 2025Vol.51 No.16By W. Kimryn Rathmell
Regulatory News Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industryCommissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas April 25, 2025Vol.51 No.16By Claire Marie Porter
Sponsored Ci4CC’s 23rd Cancer Center Summit to focus on accelerating oncology innovation through AI April 25, 2025Vol.51 No.16By Suresh S. Ramalingam and Adam Marcus
Sponsored Advancing peritoneal oncology: Innovations in surgical strategies and research April 25, 2025Vol.51 No.16By Mustafa Raoof
Guest Editorial Regulation must keep up with scientific advances April 25, 2025Vol.51 No.16By Richard M. Goldberg
PodcastThe Directors The Directors: Louis Weiner and Taofeek Owonikoko on keeping up morale amid uncertainty“We are resolute. We are committed to continuing to move the work forward.” April 18, 2025Vol.51 No.15By Paul Goldberg
